Synonyms: Andervi® | APL 502 | APL502 | TQB-2450 | TQB2450
benmelstobart is an approved drug
Compound class:
Antibody
Comment: Benmelstobart (TQB2450) is a fully humanised anti-programmed cell death 1 ligand 1 (PD-L1) monoclonal antibody. It was developed to treat advanced solid tumours by blocking the inhibitory the PD-1/PD-L1/L2 immune checkpoint.
|
Classification ![]() |
|
Compound class | Antibody |
Approved drug? | Yes. China NMPA (2024) |
International Nonproprietary Names ![]() |
|
INN number | INN |
12205 | benmelstobart |
Synonyms ![]() |
Andervi® | APL 502 | APL502 | TQB-2450 | TQB2450 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 1391 |
Other databases | |
GtoPdb PubChem SID | 507750423 |
Search PubMed clinical trials | benmelstobart |
Search PubMed titles | benmelstobart |
Search PubMed titles/abstracts | benmelstobart |